冷凍睡眠の世界市場

冷凍睡眠の世界市場は2030年までに151億米ドルに達する

2024年に44億米ドルと推定される冷凍睡眠の世界市場は、2024年から2030年にかけてCAGR 22.6%で成長し、2030年には151億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである宇宙旅行ソリューションは、CAGR24.0%を記録し、分析期間終了時には94億米ドルに達すると予測されます。医療ブレークスルー分野の成長率は、分析期間でCAGR 21.2％と推定されます。

米国市場は12億米ドル、中国はCAGR 21.4％で成長すると予測

米国の冷凍睡眠市場は、2024年に12億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに23億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは21.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ20.9%と19.4%と予測されています。欧州では、ドイツがCAGR約15.4%で成長すると予測されています。

世界の冷凍睡眠市場- 主要動向と促進要因のまとめ

冷凍睡眠が航空宇宙、医療科学、未来派のイノベーションサークルで関心を集めている理由とは？

仮死状態や治療的低体温療法とも呼ばれる冷凍睡眠は、長期の宇宙旅行や高度な医療介入、さらには人類の長寿科学に革命をもたらす可能性があるとして、注目が高まっています。このコンセプトは、人の体温を急激に下げ、代謝プロセスを停止に近い状態まで低下させることで、効果的に身体を静止状態にするものです。宇宙開発において、冷凍睡眠は、資源の制限、心理的ストレス、長年のミッションにおける老化など、恒星間旅行の課題を克服するための可能な解決策と考えられています。代謝活動を低下させることは、酸素、食料、水の必要性を減少させることを意味し、宇宙船はより少ない物資で、研究と生存のためのより多くの機器を運ぶことができます。医療用途では、心停止、脳卒中、重度の外傷を負った患者の神経機能を維持するために、治療的低体温療法がすでに使用されており、極低温技術の現実世界での実行可能性が実証されています。冷凍睡眠の広範なビジョンは、外傷患者に対する仮死状態、パンデミック時の選択的冬眠、あるいは医学的ブレークスルーを待つ人々のための時間遅延旅行などの将来の可能性を包含しています。冷凍睡眠は、その最も野心的な応用において、まだ大部分が実験的で理論的な技術であるが、低温生物学、航空宇宙工学、そして推測医学の融合における学際的なフロンティアを体現しています。極限状態における人間の能力を変革するその可能性は、世界中の研究資金、概念的ミッション、倫理的議論を刺激し続けています。

技術革新はどのように冷凍睡眠を実用化に近づけているのか？

冷凍睡眠は、かつてはSFの世界にとどまっていたが、極低温工学、生物工学、システム制御における大きな技術進歩のおかげで、着実に実現可能な方向に向かっています。研究者たちは、不可逆的な細胞損傷を引き起こすことなく、安全に体温を下げる方法を理解する上で飛躍的な進歩を遂げました。凍結中に組織内で氷の結晶が形成されるのを防ぐ凍結保護剤溶液の革新は、細胞の生存率と臓器の保存を向上させ、より広範な凍結保存のための基礎的なブレークスルーとなっています。NASAをはじめとする宇宙機関は、医薬品や温度調節システムを用いて制御された代謝抑制が可能かどうかを評価する「トルポ誘発」研究に投資しており、将来の宇宙飛行士が数ヶ月に及ぶ冬眠に入ることを可能にする可能性があります。バイタル監視、薬剤投与、環境条件の調整をリアルタイムで行える自動生命維持システムも開発中であり、実行可能な冷凍睡眠プロトコルに必要なインフラを形成しています。さらに、人工冬眠の研究は、クマや北極リスのような、自然に長期の冬眠状態に入る動物の研究によって導かれています。これらの動物から得られた遺伝的・代謝的マーカーは、人間が同様のプロセスをどのように再現できるかをモデル化するのに役立っています。まだ初期段階ではあるが、人工知能は、冷凍睡眠サイクル中のリアルタイムの健康診断や緊急介入を管理するために研究されています。組織再生と蘇生技術の並行的な進歩により、人間の冬眠という長年の夢は、徐々に推測の域から研究の裏付けを得た可能性へと近づいています。

冷凍睡眠が実用化されるためには、どのような倫理的、生理学的、規制的ハードルを乗り越えなければならないのか？

冷凍睡眠技術の進歩は、倫理的、生理学的、規制上の重要な課題を提起しています。生理学的見地から、冷凍睡眠の安全な導入と逆転は、複雑で未知の部分が多いです。治療的低体温の短時間のエピソードでさえ、血液凝固障害、組織虚血、不整脈などの合併症を引き起こす可能性があります。これを長期の冷凍保存に拡大すると、臓器不全、細胞分解、蘇生時の認知機能低下など、予測できないリスクが生じる可能性があります。また、長期間にわたる深い代謝抑制が免疫機能やマイクロバイオームにどのような影響を与えるかについての理解も限られています。倫理的にも、個人を仮死状態に置くということは、インフォームドコンセント、長期的な監護権、休眠中の法的身元、不利な結果を招いた場合の責任など、難しい問題を提起することになります。特に冷凍睡眠が何年も何十年も続く場合、誰が睡眠者のケアを監督する責任があるのだろうか？宇宙ミッションの場合、緊急時やあらかじめ決められた間隔で蘇生が義務付けられるのか、また誰がそのような決定を下すのか。規制面では、現在の枠組みでは、医療や航空宇宙における冷凍睡眠の使用を明確に規定するものはないです。規制機関は、機器の安全性、生物学的リスク評価、倫理遵守に関する新たな基準を確立する必要があります。また、透明性のある試験や、生命倫理学者、臨床医、政策立案者を含む学際的な監督を通じて、社会的信頼を築く必要があります。このような保護措置がなければ、たとえ最先端の技術であっても、一般への普及や制度的な受け入れの障壁に直面する可能性があります。

世界の冷凍睡眠市場開拓を加速する主な促進要因は？

世界の冷凍睡眠市場の成長は、科学的野心、戦略的宇宙探査目標、および低温生物学や再生医療などの隣接分野におけるブレークスルーの収束によって牽引されています。NASAやESAのような宇宙機関は、深宇宙旅行の物流や生理学的制約に対処する手段として、体温誘導の研究に積極的に資金を提供しています。代謝の必要性を減らし、生命維持コストを削減し、精神衛生を強化した状態で、人間を火星、あるいはさらに遠くへ送ることができる可能性は、強力な動機付けとなります。ヘルスケア分野では、より優れた臓器保存技術、脳損傷管理、外傷対応ソリューションに対する緊急のニーズが、冷凍睡眠開発と重なる極低温研究への投資を後押ししています。長寿科学と人間強化への関心の高まりも重要な推進力であり、冷凍睡眠を選択的静止や疾病延期のための将来の道筋と考えるベンチャーキャピタリスト、未来学者、バイオテクノロジーイノベーターから注目を集めています。一方、SpaceX社やBlue Origin社などの非公開会社による宇宙旅行や惑星間植民地化の普及は、過酷な環境下での人類の生存期間を延長する技術を開発する商業的なインセンティブを生み出します。学術機関、特に神経科学、航空宇宙医学、代謝科学の分野では、実現可能性調査を実施するために、公的機関や民間機関との協力がますます増えています。国民の想像力が技術的準備と一致し、宇宙植民地化や気候危機のような存亡に関わる課題が長期的な生存計画を促す中、冷凍睡眠は研究のフロンティアとして、また先見の明のある市場機会として勢いを増しています。

セグメント

種類（宇宙旅行ソリューション、医療ブレークスルー、長寿・延命）、技術（凍結保存技術、神経保存、蘇生・生き返り）

調査対象企業の例（全48社）

• Advanced Research Systems
• Alcor Life Extension Foundation
• American Cryonics Society
• Atelerix Limited
• BioLife Solutions
• Brooks Automation Inc.
• Chart Industries Inc.
• Cryonics Institute
• CryoTech Nordic
• CryoWorks Inc.
• CryoZone
• Evolution Space
• KrioRus
• Legacy
• Maybell Quantum
• Northrop Grumman Corporation
• Quantum Brilliance
• RICOR Cryogenic & Vacuum Systems
• Shuimu BioSciences
• Sumitomo Heavy Industries

関税影響係数

世界産業アナリストは、本社の国、製造拠点、輸出と輸入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• その他の地域

第4章 競合

Global Cryosleep Market to Reach US$15.1 Billion by 2030

The global market for Cryosleep estimated at US$4.4 Billion in the year 2024, is expected to reach US$15.1 Billion by 2030, growing at a CAGR of 22.6% over the analysis period 2024-2030. Space Travel Solutions, one of the segments analyzed in the report, is expected to record a 24.0% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Medical Breakthroughs segment is estimated at 21.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 21.4% CAGR

The Cryosleep market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.9% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.4% CAGR.

Global Cryosleep Market - Key Trends & Drivers Summarized

Why Is Cryosleep Gaining Interest Across Aerospace, Medical Science, and Futurist Innovation Circles?

Cryosleep, also referred to as suspended animation or therapeutic hypothermia, is capturing increasing attention for its potential to revolutionize long-term space travel, advanced medical interventions, and even human longevity science. The concept involves drastically lowering a person’s body temperature to a state where metabolic processes are slowed to near-halt, effectively placing the body into a stasis-like condition. In space exploration, cryosleep is seen as a possible solution for overcoming the challenges of interstellar travel, including resource limitations, psychological stress, and aging during years-long missions. Reducing metabolic activity would mean less need for oxygen, food, and water, allowing spacecraft to carry fewer supplies and more equipment for research and survival. In medical applications, therapeutic hypothermia has already been used to preserve neurological function in patients experiencing cardiac arrest, stroke, or severe trauma, demonstrating real-world viability of cryogenic techniques. The broader vision of cryosleep encompasses future possibilities such as suspended animation for trauma patients, elective hibernation during pandemics, or even time-delay travel for those awaiting medical breakthroughs. While the technology is still largely experimental and theoretical in its most ambitious applications, cryosleep embodies a multidisciplinary frontier at the convergence of cryobiology, aerospace engineering, and speculative medicine. Its potential for transforming human capability in extreme conditions continues to inspire research funding, conceptual missions, and ethical debate worldwide.

How Are Technological Innovations Pushing Cryosleep Closer to Practical Application?

Cryosleep, once confined to science fiction, is moving steadily toward plausibility thanks to major technological advances in cryogenics, bioengineering, and systems control. Researchers have made strides in understanding how to safely lower body temperatures without causing irreversible cellular damage-a key barrier that had previously limited the use of long-term hypothermia. Innovations in cryoprotectant solutions, which prevent ice crystal formation in tissues during freezing, are improving cell viability and organ preservation, serving as foundational breakthroughs for broader cryostasis. NASA and other space agencies have invested in “torpor-inducing” studies to assess whether controlled metabolic suppression can be achieved using pharmaceuticals and temperature regulation systems, potentially enabling future astronauts to enter months-long hibernation. Automated life support systems capable of monitoring vitals, administering drugs, and adjusting environmental conditions in real time are also under development, forming the infrastructure needed for any viable cryosleep protocol. Furthermore, research into synthetic hibernation is being guided by studies of animals like bears and arctic ground squirrels that naturally enter prolonged torpor states. Genetic and metabolic markers from these animals are helping scientists model how humans might replicate similar processes. Though still in early stages, artificial intelligence is being explored to manage real-time health diagnostics and emergency interventions during cryosleep cycles. With parallel advancements in tissue regeneration and resuscitation techniques, the long-held dream of human hibernation is gradually inching from speculative fiction to research-backed possibility.

What Ethical, Physiological, and Regulatory Hurdles Must Be Overcome for Cryosleep to Become Viable?

The advancement of cryosleep technologies raises significant ethical, physiological, and regulatory challenges that must be addressed before broader adoption is feasible. From a physiological standpoint, the safe induction and reversal of cryosleep remains complex and fraught with unknowns. Even brief episodes of therapeutic hypothermia can result in complications such as blood clotting disorders, tissue ischemia, or cardiac arrhythmias. Scaling this to long-term cryostasis could introduce unpredictable risks related to organ failure, cellular degradation, and cognitive decline upon revival. There is also limited understanding of how deep metabolic suppression might affect immune function or the microbiome over extended periods. Ethically, the prospect of placing individuals in suspended animation raises difficult questions around informed consent, long-term custodianship, legal identity during dormancy, and liability in case of adverse outcomes. Who is responsible for overseeing the sleeper’s care, especially if cryosleep extends for years or decades? In space missions, would revival be mandatory under emergencies or at predetermined intervals, and who would make such decisions? On the regulatory front, no current frameworks explicitly govern the use of cryosleep in either medical or aerospace contexts. Regulatory agencies would need to establish new standards for device safety, biological risk assessment, and ethical compliance. Public trust would also need to be built through transparent trials and interdisciplinary oversight involving bioethicists, clinicians, and policy-makers. Without these safeguards, even the most advanced technologies could face barriers to public adoption and institutional acceptance.

What Are the Primary Drivers Accelerating the Development of the Global Cryosleep Market?

The growth in the global cryosleep market is being driven by a convergence of scientific ambition, strategic space exploration goals, and breakthroughs in adjacent fields such as cryobiology and regenerative medicine. Space agencies like NASA and ESA are actively funding research into torpor induction as a means of addressing the logistical and physiological constraints of deep space travel. The potential to send humans to Mars or even further with reduced metabolic needs, lower life support costs, and enhanced mental health preservation is a powerful motivator. In the healthcare sector, the urgent need for better organ preservation techniques, brain injury management, and trauma response solutions is propelling investment into cryogenic research that overlaps with cryosleep development. The burgeoning interest in longevity science and human enhancement is another significant driver, attracting attention from venture capitalists, futurists, and biotech innovators who see cryosleep as a future pathway for elective stasis or disease deferral. Meanwhile, the popularization of space tourism and interplanetary colonization by private companies such as SpaceX and Blue Origin creates a compelling commercial incentive to develop technologies that extend human viability in harsh environments. Academic institutions, especially in the fields of neuroscience, aerospace medicine, and metabolic science, are increasingly collaborating with public and private organizations to conduct feasibility studies. As public imagination aligns with technological readiness, and as existential challenges such as space colonization or climate crises prompt long-term survival planning, cryosleep is gaining momentum as both a research frontier and a visionary market opportunity.

SCOPE OF STUDY:

The report analyzes the Cryosleep market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Space Travel Solutions, Medical Breakthroughs, Longevity & Life Extension); Technology (Cryopreservation Techniques, Neural Preservation, Revival & Reanimation)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

• Advanced Research Systems
• Alcor Life Extension Foundation
• American Cryonics Society
• Atelerix Limited
• BioLife Solutions
• Brooks Automation Inc.
• Chart Industries Inc.
• Cryonics Institute
• CryoTech Nordic
• CryoWorks Inc.
• CryoZone
• Evolution Space
• KrioRus
• Legacy
• Maybell Quantum
• Northrop Grumman Corporation
• Quantum Brilliance
• RICOR Cryogenic & Vacuum Systems
• Shuimu BioSciences
• Sumitomo Heavy Industries

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Cryosleep - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advancements in Space Travel Concepts Throw the Spotlight on Cryosleep as a Long-Duration Human Preservation Strategy
  • Rising Interest in Deep Space Exploration Drives Demand for Feasibility Studies on Cryogenic Human Suspension
  • Push for Medical Applications of Therapeutic Hypothermia Propels Research into Controlled Metabolic Reduction
  • Integration of AI and Remote Monitoring Technologies Strengthens Cryosleep Viability in Isolated Environments
  • Growth in Space Tech Investments and Interplanetary Missions Fuels Cryogenic Stasis System Development
  • Interest in Induced Torpor for Trauma Stabilization Drives Overlap Between Space and Critical Care Applications
  • Ethical and Biosecurity Concerns in Human Cryopreservation Spur Regulatory and Policy Dialogue
  • Private Space Tourism Initiatives Throw the Spotlight on Human Comfort and Health Optimization in Transit
  • Technological Innovation in Cryogenic Life Support and Reanimation Methods Expands Development Possibilities
  • Synthetic Biology and Metabolic Engineering Trends Offer New Approaches to Human Energy Conservation
  • Exploration of Cross-Species Hibernation Biology Supports Cryosleep Proof-of-Concept Studies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cryosleep Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cryosleep by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Cryosleep by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Space Travel Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Space Travel Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Medical Breakthroughs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Medical Breakthroughs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Longevity & Life Extension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Longevity & Life Extension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Cryopreservation Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Cryopreservation Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Neural Preservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Neural Preservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Revival & Reanimation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Revival & Reanimation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 16: USA Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 17: USA 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 18: USA Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 19: USA 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• CANADA
  • TABLE 20: Canada Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Canada 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 22: Canada Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 23: Canada 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• JAPAN
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 24: Japan Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 25: Japan 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 26: Japan Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Japan 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• CHINA
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 28: China Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 29: China 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 30: China Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 31: China 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• EUROPE
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Cryosleep by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: Europe 6-Year Perspective for Cryosleep by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 34: Europe Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 35: Europe 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 36: Europe Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 37: Europe 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• FRANCE
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: France 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 40: France Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 41: France 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• GERMANY
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 42: Germany Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 43: Germany 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 44: Germany Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Germany 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• ITALY
  • TABLE 46: Italy Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Italy 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 48: Italy Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 49: Italy 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• UNITED KINGDOM
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 50: UK Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: UK 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 52: UK Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 53: UK 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 55: Rest of Europe 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Rest of Europe 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• ASIA-PACIFIC
  • Cryosleep Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Asia-Pacific 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Asia-Pacific 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Cryosleep by Type - Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Rest of World 6-Year Perspective for Cryosleep by Type - Percentage Breakdown of Value Sales for Space Travel Solutions, Medical Breakthroughs and Longevity & Life Extension for the Years 2025 & 2030
  • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Cryosleep by Technology - Cryopreservation Techniques, Neural Preservation and Revival & Reanimation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 65: Rest of World 6-Year Perspective for Cryosleep by Technology - Percentage Breakdown of Value Sales for Cryopreservation Techniques, Neural Preservation and Revival & Reanimation for the Years 2025 & 2030

IV. COMPETITION